pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
RT-002
Sarcopenia
Ridgeline Therapeutics LLC
0
catalysts
Phase 2
RT-100
Systolic Heart Failure (HFrEF)
Renova Therapeutics Inc
0
catalysts
Preclinical
RT-200
Type 2 Diabetes
Renova Therapeutics Inc
0
catalysts
Phase 1
RTT-1
Rett Syndrome
Grann Pharmaceuticals Inc
← prev
page 150 of 271
next →
131
Pain
89
Neurology
1
0
catalysts
Phase 3
RTX-015
Retinitis Pigmentosa (Retinitis)
Ray Therapeutics Inc
0
catalysts
RUBRACA
RUBRACA (RUCAPARIB CAMSYLATE)
pharmaand GmbH
0
catalysts
RUXIENCE
RUXIENCE (RITUXIMAB-PVVR)
$PFE
PFIZER INC
0
catalysts
Phase 2
RV-01
Castration-Resistant Prostate Cancer (CRPC)
Radiopharm Ventures LLC
0
catalysts
Phase 1
RV-1770
Respiratory Syncytial Virus (RSV) Infections
Hualan Biological Vaccine Inc
0
catalysts
Preclinical
RVB-001
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
0
catalysts
Preclinical
RVB-003
Netherton Syndrome (Bamboo Hair)
ResVita Bio Inc
0
catalysts
Phase 2
RX-0301
Hepatocellular Carcinoma
Zhejiang Haichang Biotechnology Co Ltd
0
catalysts
Phase 2
RXRG-001
Xerostomia
RiboX (Shanghai) Therapeutics Co Ltd
0
catalysts
Phase 2
RY-104
Wet (Neovascular / Exudative) Macular Degeneration
Neuracle Genetics Inc
0
catalysts
RYBREVANT
RYBREVANT (AMIVANTAMAB-VMJW)
Janssen Biotech Inc
0
catalysts
RYBREVANT FASPRO
RYBREVANT FASPRO (AMIVANTAMAB AND HYALURONIDASE-LPUJ)
Janssen Biotech Inc
0
catalysts
RYSTIGGO
RYSTIGGO (ROZANOLIXIZUMAB-NOLI)
UCB SA
0
catalysts
RYTELO
RYTELO (IMETELSTAT SODIUM)
1. INDICATIONS AND USAGE RYTELO is indicated for the treatment of adult patie…
Telomerase reverse transcriptase
$GERN
GERON CORP
0
catalysts
Phase 2
RZ-001
Glioblastoma Multiforme (GBM)
Rznomics Inc
0
catalysts
Marketed
Radicava
Radicava (edaravone)
Amyotrophic Lateral Sclerosis
$SGIOF
SHIONOGI & CO LTD
0
catalysts
Phase 2
Radspherin
Colorectal Cancer
Oncoinvent ASA
0
catalysts
Preclinical
Rare Disease
Unspecified Rare Disease
Dawn Sea Therapeutics
0
catalysts
Phase 3
ReNu
Osteoarthritis
$ORGO
Organogenesis Holdings Inc.
0
catalysts
Preclinical
Recombinant AAT
Charcot-Marie-Tooth Disease Type I A
Ageronix SA
0
catalysts
Preclinical
Recombinant Alpha-1 Antitrypsin Replacement for Alpha-1 Antitrypsin Deficiency
Alpha-1 Antitrypsin Deficiency (A1AD)
Caravella Biopharma SA
0
catalysts
Preclinical
Recombinant Human Neuroglobin (rNgb)
Carbon Monooxide Poisoning
Globin Solutions Inc
0
catalysts
Preclinical
Recombinant Peptide to Inhibit Type I Collagen for Frozen Shoulder Syndrome
Frozen Shoulder Syndrome
Ortholevo Inc
0
catalysts
Preclinical
Recombinant Protein to Activate p38 MAP Kinase for Round Worm Infections
Nematodal (Round Worm) Infections
University of California San Diego
0
catalysts
Preclinical
Recombinant Protein to Antagonize TGF beta for Immunology, Dermatology, Gastrointestinal and Musculoskeletal Disorders
Oral Mucositis
Allander Biotechnologies LLC
0
catalysts
Marketed
Regenecyte
Blood Cancer
StemCyte Inc
0
catalysts
